Mudita Advisors LLP Maxcyte, Inc. Transaction History
Mudita Advisors LLP
- $184 Million
- Q1 2025
A detailed history of Mudita Advisors LLP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mudita Advisors LLP holds 3,328,441 shares of MXCT stock, worth $7.56 Million. This represents 4.94% of its overall portfolio holdings.
Number of Shares
3,328,441
Previous 3,223,407
3.26%
Holding current value
$7.56 Million
Previous $13.4 Million
32.24%
% of portfolio
4.94%
Previous 7.89%
Shares
11 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.8 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$18.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.6 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.4 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $231M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...